tak-994
Small moleculeexperimental
Clinical trial activity
6 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
5
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started May 1, 2019 (NCT03933488)
Timeline
Indications
Mechanism of action
- Orexin receptorAGONIST
Orexin receptor agonist
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04820842 | Phase 2 | Apr 30, 2021 | Takeda |
| NCT04833049 | Phase 1 | Apr 14, 2021 | Takeda |
| NCT04745767 | Phase 1 | Feb 16, 2021 | Takeda |
| NCT04551079 | Phase 1 | Sep 23, 2020 | Takeda |
| NCT04096560 | Phase 1 | Jan 2, 2020 | Takeda |
| NCT03933488 | Phase 1 | May 1, 2019 | Takeda |
Showing 6 of 6 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Takeda | For profit | 6 | 6 | 2 | 2019 |
1 organizations
Page 1 / 1